Table 1

Characteristics of the study population by dipping status

VariableDipperNon-dipperReverse dipperp Value
Patients, n177370171
WCH, n (15.60%)50 (44.64%)53 (47.32%)9 (8.03%)<0.001
SH, n (84.40%)127 (20.95%)317 (52.31)162 (26.73%)<0.001
Age, year56.08±14.5058.79±13.5464.91±11.97*†<0.001
Male/female, n100/77200/17090/810.761
Current smokers, n, %42 (23.73)118 (31.89)55 (32.16)0.115
Diabetes mellitus, n, %36 (20.34)95 (25.68)58 (33.92)*0.015
Fasting blood glucose, mmol/L5.12±1.905.21±1.435.85±3.02*†0.006
Triglycerides, mmol/L2.23±1.901.82±1.25*1.63±1.20*<0.001
Total cholesterol, mmol/L4.74±1.034.58±0.934.63±1.090.212
 HDL-C, mmol/L1.22±0.301.25±0.351.27±0.340.383
 LDL-C, mmol/L2.86±0.152.66±0.81*2.72±0.880.050
 VLD-C, mmol/L0.70±0.570.67±0.530.65±0.580.728
24 hour Mean SBP, ABPM, mm  Hg134.16±13.28135.44±13.79137.23±15.72*0.127
Mean SBP awakening, mm  Hg138.09±13.79136.98±13.94135.87±15.230.347
Mean SBP bedtime, mm  Hg118.31±14.49129.78±13.75*142.52±16.84*†<0.001
24 hour Mean DBP, ABPM, mm  Hg79.44±11.7980.00±10.0879.11±10.040.628
Mean DBP-awakening, mm  Hg82.53±10.8281.02±10.1078.86±9.98*†0.004
Mean DBP-bedtime, mm  Hg69.49±10.0375.20±10.05*79.94±10.93*†<0.001
Cystatin C, mg/L1.06±0.361.12±0.591.19±0.53*0.062
  • *Indicated control with dipper group p<0.05.

  • †Indicated control with non-dipper group p<0.05.

  • ABPM, ambulatory blood pressure monitoring; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; SH, sustained hypertension (office BP≥140/90 with high ABPM measurements); VLD-C, very low-density lipoprotein cholesterol; WCH, white coat hypertension (office BP ≥140/90 mm Hg with normal ABPM measurements).